Market Cap 1.85M
Revenue (ttm) 680,000.00
Net Income (ttm) -7.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,169.12%
Debt to Equity Ratio 0.00
Volume 51,889
Avg Vol 5,530,024
Day's Range N/A - N/A
Shares Out 1.06M
Stochastic %K 84%
Beta 3.01
Analysts Sell
Price Target $17.60

Company Profile

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidi...

Industry: Biotechnology
Sector: Healthcare
Phone: 202 327 5422
Address:
1025 Connecticut Avenue NW, Suite 1000, Washington, United States
Invest2Create
Invest2Create Apr. 2 at 2:43 PM
Well, instead of a launch with attendant skyrocketing that a number of us have been looking forward to, it looks like $SXTP is putting in a pause day instead. This should not be unexpected though. First, we’ve had three up days, which are often the limit for segments in many upswings. Second, the 1.80 to 2.10 or 2.20 range is a historical zone of resistance that was present from late December, 2025 into January, 2026, and again on March 11. January 21 seems similar to today. Third, given the markets’ fairly strong negative reaction this morning to Trump’s televised speech last night, combined with the onset of a three-day holiday weekend — it’s just not an environment traders want to buy into. There is also the fact that 60 Degree Pharma has not announced the launch of its Runway health partnership today as expected. They might well be holding such an announcement for release perhaps next Monday, when it could have a better effect on the stock. Holding for next week.
0 · Reply
STLHD
STLHD Apr. 2 at 1:23 PM
$SXTP No PR yet on today's launch of Runway Health partnership. Let's run, Sixty Degrees Pharma!
1 · Reply
MonstroTrader
MonstroTrader Apr. 2 at 12:45 AM
$SXTP They returned 280,000 shares today. Last time we were at these levels, it popped to $8.62. Can we get a repeat run? I'm looking for at least $2.50 to start
0 · Reply
_Jean123
_Jean123 Apr. 1 at 8:53 PM
$SXTP $SXTP 🚨 THE DILUTION THREAT IS GONE!!! 🚨 Read the fine print, the ATM is officially EXHAUSTED! 🤯 The shorts were betting their lives on a new offering to save them, and now they are TRAPPED with a microscopic 1.2M float! 🔥🩳🔥 This is a ridiculous $5M Market Cap company sitting on a $1.1 BILLION target market that just confirmed 65% revenue growth. And now... NO MORE SHARES TO DUMP ON US! The artificial ceiling is broken. When the volume hits tomorrow for the Runway Health launch, $3 is going to look like a joke. Next stop $8! If you are shorting this, RIP to your account. LFG!!! 💎🙌🚀🤑
0 · Reply
ItTakesItAll
ItTakesItAll Apr. 1 at 7:04 PM
$SXTP 10%+
0 · Reply
STLHD
STLHD Apr. 1 at 3:10 PM
$SXTP Should be a PR tomorrow on the Runway Health partnership launch which should boost ARAKODA sales.
2 · Reply
Eses262626
Eses262626 Apr. 1 at 7:52 AM
$SXTP $ARBK is currently the smallest-listed stock on the US stock exchange with 333,000 shares, but it will soon be on the radar of investment groups and could reach double digits. I think you should reserve your spot now.💕💕
1 · Reply
Invest2Create
Invest2Create Apr. 1 at 3:28 AM
$SXTP is beginning to exhibit a pattern similar to what $SMX came to exhibit in late November, 2025. Instead of exhausting itself with a large, one-day upmove as it has the past two upswings on January 22 and March 11 — gaining just 15.9% on 10x volume, $SXTP seems to be building up to perhaps a larger move later this holiday-shortened week, much as $SMX did during Thanksgiving week last fall, with $SMX exhibiting a similar combination of 25x volume increase, moderate 10% price gain and bottoming action on November 21, 2025, as $SXTP has on Tuesday, March 31. Let’s remember that algorithms like, lock in on, even replicate, similar patterns. $SXTP is also looking at potential addressable markets at over a billion dollars, all with a current market cap of $4.32M and a float of just 2.40M shares.
2 · Reply
EternalMaze
EternalMaze Apr. 1 at 3:18 AM
$SXTP The company reported a 65% increase in net product revenue, reaching $1.0 million in 2025 compared to $607.6K in 2024. This growth was largely driven by its lead product, ARAKODA (tafenoquine)
0 · Reply
LewisDaKat
LewisDaKat Mar. 31 at 9:00 PM
$SXTP 60 Degrees Pharmaceuticals Announces 2025 Annual Results https://marketwirenews.com/stock/sxtp/news/60-degrees-pharmaceuticals-announces-2025-annual-res-4634576434500405.html?utm_source=stocktwits
0 · Reply
Latest News on SXTP
60 Degrees Pharmaceuticals Announces 2025 Annual Results

Mar 31, 2026, 7:01 AM EDT - 2 days ago

60 Degrees Pharmaceuticals Announces 2025 Annual Results


What's Going On With 60 Degrees Pharmaceuticals On Friday?

Mar 13, 2026, 9:11 AM EDT - 20 days ago

What's Going On With 60 Degrees Pharmaceuticals On Friday?


60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results

Nov 13, 2025, 1:51 PM EST - 5 months ago

60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results


60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results

Aug 13, 2025, 4:14 PM EDT - 8 months ago

60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results


60 Degrees Pharmaceuticals Announces First Quarter 2025 Results

May 15, 2025, 4:31 PM EDT - 11 months ago

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results


Invest2Create
Invest2Create Apr. 2 at 2:43 PM
Well, instead of a launch with attendant skyrocketing that a number of us have been looking forward to, it looks like $SXTP is putting in a pause day instead. This should not be unexpected though. First, we’ve had three up days, which are often the limit for segments in many upswings. Second, the 1.80 to 2.10 or 2.20 range is a historical zone of resistance that was present from late December, 2025 into January, 2026, and again on March 11. January 21 seems similar to today. Third, given the markets’ fairly strong negative reaction this morning to Trump’s televised speech last night, combined with the onset of a three-day holiday weekend — it’s just not an environment traders want to buy into. There is also the fact that 60 Degree Pharma has not announced the launch of its Runway health partnership today as expected. They might well be holding such an announcement for release perhaps next Monday, when it could have a better effect on the stock. Holding for next week.
0 · Reply
STLHD
STLHD Apr. 2 at 1:23 PM
$SXTP No PR yet on today's launch of Runway Health partnership. Let's run, Sixty Degrees Pharma!
1 · Reply
MonstroTrader
MonstroTrader Apr. 2 at 12:45 AM
$SXTP They returned 280,000 shares today. Last time we were at these levels, it popped to $8.62. Can we get a repeat run? I'm looking for at least $2.50 to start
0 · Reply
_Jean123
_Jean123 Apr. 1 at 8:53 PM
$SXTP $SXTP 🚨 THE DILUTION THREAT IS GONE!!! 🚨 Read the fine print, the ATM is officially EXHAUSTED! 🤯 The shorts were betting their lives on a new offering to save them, and now they are TRAPPED with a microscopic 1.2M float! 🔥🩳🔥 This is a ridiculous $5M Market Cap company sitting on a $1.1 BILLION target market that just confirmed 65% revenue growth. And now... NO MORE SHARES TO DUMP ON US! The artificial ceiling is broken. When the volume hits tomorrow for the Runway Health launch, $3 is going to look like a joke. Next stop $8! If you are shorting this, RIP to your account. LFG!!! 💎🙌🚀🤑
0 · Reply
ItTakesItAll
ItTakesItAll Apr. 1 at 7:04 PM
$SXTP 10%+
0 · Reply
STLHD
STLHD Apr. 1 at 3:10 PM
$SXTP Should be a PR tomorrow on the Runway Health partnership launch which should boost ARAKODA sales.
2 · Reply
Eses262626
Eses262626 Apr. 1 at 7:52 AM
$SXTP $ARBK is currently the smallest-listed stock on the US stock exchange with 333,000 shares, but it will soon be on the radar of investment groups and could reach double digits. I think you should reserve your spot now.💕💕
1 · Reply
Invest2Create
Invest2Create Apr. 1 at 3:28 AM
$SXTP is beginning to exhibit a pattern similar to what $SMX came to exhibit in late November, 2025. Instead of exhausting itself with a large, one-day upmove as it has the past two upswings on January 22 and March 11 — gaining just 15.9% on 10x volume, $SXTP seems to be building up to perhaps a larger move later this holiday-shortened week, much as $SMX did during Thanksgiving week last fall, with $SMX exhibiting a similar combination of 25x volume increase, moderate 10% price gain and bottoming action on November 21, 2025, as $SXTP has on Tuesday, March 31. Let’s remember that algorithms like, lock in on, even replicate, similar patterns. $SXTP is also looking at potential addressable markets at over a billion dollars, all with a current market cap of $4.32M and a float of just 2.40M shares.
2 · Reply
EternalMaze
EternalMaze Apr. 1 at 3:18 AM
$SXTP The company reported a 65% increase in net product revenue, reaching $1.0 million in 2025 compared to $607.6K in 2024. This growth was largely driven by its lead product, ARAKODA (tafenoquine)
0 · Reply
LewisDaKat
LewisDaKat Mar. 31 at 9:00 PM
$SXTP 60 Degrees Pharmaceuticals Announces 2025 Annual Results https://marketwirenews.com/stock/sxtp/news/60-degrees-pharmaceuticals-announces-2025-annual-res-4634576434500405.html?utm_source=stocktwits
0 · Reply
STLHD
STLHD Mar. 31 at 5:26 PM
$SXTP here's the 1/22 Runway Health partnership PR that tripled the price in 1 day. The partnership launches Thursday. Another low float triple on deck? https://investors.60degreespharma.com/news-releases/news-release-details/60-degrees-pharmaceuticals-announces-partnership-runway-health
0 · Reply
Joe_088
Joe_088 Mar. 31 at 2:30 PM
0 · Reply
STLHD
STLHD Mar. 31 at 2:29 PM
$SXTP Tripled in 1 day on 1/22. 2025 annual results published today. Net product revenues increased 65%. https://www.globenewswire.com/news-release/2026/03/31/3265329/0/en/60-Degrees-Pharmaceuticals-Announces-2025-Annual-Results.html
0 · Reply
durocali
durocali Mar. 31 at 2:16 PM
$SXTP not many shares left to borrow here with high borrow fees but lacking volume at the moment. hate using the term "skyrocket" when it rarely applies, but if more eyes open up with positive catalysts and this extremely low float it may very well do just that.
0 · Reply
STLHD
STLHD Mar. 31 at 2:06 PM
$SXTP Partnership with Runway Health commences Thursday, 4/2. ARAKODA is the only FDA-approved once weekly malaria prevention med for international travelers. Low float: only 1.14 mil. She's a runner!
0 · Reply
Invest2Create
Invest2Create Mar. 31 at 12:25 PM
$SXTP is breaking upward on positive earnings news. Look for one more likely retest of support at the bullish-crossing 20 and 50 hourly SMA lines at 1.50, which should be a good to great entry point either in the Premarket or Regular Session open, and then $SXTP should be off and running upward. With the 7 AM hourly wakeup volume around just 600,000 shares, 60 Degrees Pharma is a long way from being overbought, and with a 200 Day SMA of 4.83 and an Analysts’ Target Price of 24.00 on Finviz, it has plenty of room to run! So, today, Tuesday, is the day instead. Go get ‘em and good trading!
0 · Reply
_Jean123
_Jean123 Mar. 31 at 11:38 AM
$SXTP $SXTP 🚨 WAKE UP WALL STREET! 🚨 The 10-K is OUT and the fear is officially GONE! 💥 We are sitting on a microscopic 1.2M FLOAT and already blasted through half a million in volume before the sun is even up! 🤯 Do the math: A ridiculous $5M Market Cap for a biotech with a 100% cure rate in Babesiosis and a $1.1 BILLION target market?! 🧬💰 The shorts are completely TRAPPED and today they BURN. 🔥🩳 That massive pre-market liquidity test was just a teaser of what's coming. Once the opening bell rings and the big volume hits, $3 is just a pitstop and $8 is the destination! LFG! 🚀💎🙌
0 · Reply
durocali
durocali Mar. 31 at 11:33 AM
$SXTP a moderate squeeze of the large amount of short int would appear close-to-near imminent here given the micro float. hopefully they don't flub the timing of any new dilution announcements. long this stock on taf advancement..
0 · Reply
DARKP00L
DARKP00L Mar. 31 at 11:25 AM
$SXTP 07:10 on Mar. 31 2026 60 Degrees Pharmaceuticals Announces 2025 Annual Results #tradeideas
0 · Reply
maxamillion001
maxamillion001 Mar. 31 at 11:18 AM
$SXTP watching this - could squeeze Short Interest 484,774 shares - source: NASDAQ Short Interest Ratio 1.84 Days to Cover Short Interest % Float 42.50 % - source: NASDAQ (short interest), Capital IQ (float)
0 · Reply
ItTakesItAll
ItTakesItAll Mar. 31 at 11:16 AM
$SXTP Adding again, 1.60s, good Q results.
0 · Reply
maxamillion001
maxamillion001 Mar. 31 at 11:14 AM
$SXTP https://www.stocktitan.net/news/SXTP/60-degrees-pharmaceuticals-announces-2025-annual-hl4dlds718z0.html
0 · Reply